These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10493839)

  • 1. Blood markers of cardiovascular disease.
    Gershlick AH
    Eur Heart J; 1999 Oct; 20(20):1443-4. PubMed ID: 10493839
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease.
    Gorog DA
    J Am Coll Cardiol; 2010 Jun; 55(24):2701-9. PubMed ID: 20538163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin D-dimer and cardiovascular risk.
    Lowe GD
    Semin Vasc Med; 2005 Nov; 5(4):387-98. PubMed ID: 16302161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of plasma coagulation by retransfusion of unwashed drainage blood after hip joint arthroplasty: a prospective study.
    Duchow J; Ames M; Hess T; Seyfert U
    J Arthroplasty; 2001 Oct; 16(7):844-9. PubMed ID: 11607899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
    Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
    Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nonenzymatic fibrinolysis].
    Dzhurdzhev A; Atanasov K
    Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
    [No Abstract]   [Full Text] [Related]  

  • 8. [Structure, metabolism and pathophysiological importance of fibrinogen].
    Lepsanovic LJ
    Med Pregl; 1976; 29(5-6):287-94. PubMed ID: 940540
    [No Abstract]   [Full Text] [Related]  

  • 9. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D; Tsiandoulas A; Pangalou M; Koutoupa E; Rozi P; Protopappa M; Barboutis K
    Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-intensity warfarin reduces thrombin generation and fibrin turnover, but not low-grade inflammation, in men at risk of myocardial infarction.
    MacCallum PK; Rudnicka AR; Rumley A; Meade TW; Lowe GD
    Br J Haematol; 2004 Nov; 127(4):448-50. PubMed ID: 15521923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coagulation and fibrinolysis systems and atherosclerosis.
    Tanaka K; Sueishi K
    Lab Invest; 1993 Jul; 69(1):5-18. PubMed ID: 8331898
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are fibrin-related markers useful for the diagnosis of thrombosis?
    Wada H; Sakuragawa N
    Semin Thromb Hemost; 2008 Feb; 34(1):33-8. PubMed ID: 18393141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-dimer: a novel predictive marker for cardiovascular disease.
    Akgul O; Uyarel H
    Int J Cardiol; 2013 Oct; 168(5):4930-1. PubMed ID: 23916776
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why is plasma fibrinogen a cardiovascular risk factor?
    Scrutton MC; Ross-Murphy SB
    Thromb Haemost; 1994 Oct; 72(4):650-1. PubMed ID: 7878652
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrin generation and digestion in patients with angina pectoris.
    Prisco D; Paniccia R; Francalanci I; Bandinelli B; Filippini M; Bacci F; Rostagno C; Abbate R; Gensini GF
    Int J Clin Lab Res; 1995; 25(4):222-5. PubMed ID: 8788552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
    Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
    J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report.
    Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
    Thromb Haemost; 1999 Sep; 82(3):1112-6. PubMed ID: 10494773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.